NTRP

Neurotrope Inc

Halal Rating :
Questionable
Last Price $7.07 Last updated:
Market Cap -
7D Change -2.48%
1 Year Change 93.7%

Company Overview

Industries
  • Manufacturing
  • Misc.
  • Misc. Manufacturing Industries
Exchange
Next Earnings Date

Based on SEC filings and available data, Neurotrope Inc was a clinical-stage biopharmaceutical company that focused on developing novel therapeutics for neurodegenerative diseases, particularly Alzheimer's disease. The company merged with Petros Pharmaceuticals in December 2020 to form Petros Pharmaceuticals (NASDAQ: PTPI).

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
Nov. 30, 2024 $74635.0 $1.85m - - 0.00% 0.00%
Aug. 31, 2024 $154498.0 $1.62m - - 0.00% 0.00%
May 31, 2024 $188793.0 $2.14m - - 0.00% 0.00%

Company Impact

Help us evaluate Neurotrope Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Recent News & Updates